---
schema_version: "secwatch.filing_event.v1"
accession: "0001829126-25-009304"
form_type: "8-K"
ticker: "PMI"
cik: "0002030617"
company_name: "Picard Medical, Inc."
filed_at: "2025-11-19T23:59:59+00:00"
generated_at: "2026-05-16T18:35:21.970629+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# SynCardia implants Emperor Total Artificial Heart in first in vivo study

## Summary
- Three pre-clinical models successfully implanted with the Emperor TAH; all taken off bypass without issues.
- Device provided full, stable blood circulation with efficient energy use and no technical problems.
- Emperor TAH exhibited Frank-Starling response: natural pump output adjustment based on blood volume.
- Results consistent with Picard Medical's laboratory performance goals; program acceleration expected.
- Emperor platform designed as a fully implantable successor to the FDA-approved SynCardia TAH.

## SEC filing metadata
- accession: 0001829126-25-009304
- form_type: 8-K
- ticker: PMI
- cik: 0002030617
- company_name: Picard Medical, Inc.
- filed_at: 2025-11-19T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2030617/000182912625009304/0001829126-25-009304-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2030617/000182912625009304/picardmedical_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001829126-25-009304
- JSON: https://secwatch.observer/filing/0001829126-25-009304.json
- Plain text: https://secwatch.observer/filing/0001829126-25-009304.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.